Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer-Reference-Cited by-同舟云学术

Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer

Published:2020-01 Issue:1 Volume:52 Page:183-199.e9
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Cillo Anthony R.,Kürten Cornelius H.L.,Tabib Tracy,Qi Zengbiao,Onkar Sayali,Wang Ting,Liu Angen,Duvvuri Umamaheswar,Kim Seungwon,Soose Ryan J.,Oesterreich Steffi,Chen Wei,Lafyatis Robert,Bruno Tullia C.,Ferris Robert L.,Vignali Dario A.A.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference95 articles.

1. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer;Al-Shibli;Clin. Cancer Res.,2008

2. Human papillomavirus and survival of patients with oropharyngeal cancer;Ang;N. Engl. J. Med.,2010

3. destiny: diffusion maps for large-scale single-cell data in R;Angerer;Bioinformatics,2016

4. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity;Ansel;Immunity,2002

5. Head and neck cancer;Argiris;Lancet,2008

Cited by 448 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune landscape of renal cell carcinoma with metastasis to the pancreas;Urologic Oncology: Seminars and Original Investigations;2024-11

2. Single-cell analysis reveals hypoxia-induced immunosuppressive microenvironment in intrahepatic cholangiocarcinoma;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

3. Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment;2024-09-10

4. Dimension reduction, cell clustering, and cell–cell communication inference for single-cell transcriptomics with DcjComm;Genome Biology;2024-09-09

5. A comprehensive and longitudinal evaluation of the different populations of lymphoid and myeloid cells in the peripheral blood of patients treated with chemoradiotherapy for head and neck cancer;Cancer Immunology, Immunotherapy;2024-09-05